ALESSA THERAPEUTICS
Alessa Therapeutics is a pre-clinical stage company that develops localized treatments for solid organ disease.
ALESSA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2018-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.alessatherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
415-885-7810
Total Funding:
6.26 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Google Font API WordPress LetsEncrypt Organization Schema Sitelinks Search Box
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Aldexa Therapeutics
Aldexa Therapeutics develops treatments for the dry form of age-related macular degeneration eye disease.
Atlee Biotech
Atlee Biotech develops novel treatments for acute disorders.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Lysosomal Therapeutics
Lysosomal Therapeutics deliver cures for neurodegenerative diseases.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Current Employees Featured
Founder
Investors List
Mission BioCapital
Mission BioCapital investment in Venture Round - Alessa Therapeutics
Official Site Inspections
http://www.alessatherapeutics.com Semrush global rank: 5.2 M Semrush visits lastest month: 1.5 K
- Host name: 151.101.2.159
- IP address: 151.101.2.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Alessa Therapeutics"
Alessa Therapeutics Announces Closing $15M Seed Financing
SAN CARLOS, CA (December 12, 2024) – Alessa Therapeutics, Inc., a clinical-stage drug development company pioneering an innovative and proprietary localized drug delivery …See details»
Alessa Therapeutics Appoints Cam Gallagher as President & Chief ...
Dec 16, 2024 “The opportunity to lead an organization with such a strong commitment to improving the lives of cancer patients aligns perfectly with my passion for developing novel …See details»
Alessa Therapeutics - Crunchbase Company Profile
Alessa Therapeutics is a pre-clinical stage company that develops localized treatments for solid organ disease.See details»
Alessa Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Alessa Therapeutics, Inc. of San Francisco, CA. Get the latest business insights from Dun & Bradstreet.See details»
Alessa Therapeutics - Overview, News & Similar companies
Feb 22, 2022 View Alessa Therapeutics (www.alessatherapeutics.com) location in California, United States , revenue, industry and description. Find related and similar companies as well …See details»
Alessa Therapeutics, Inc. Company Profile | San Carlos, CA ...
Find company research, competitor information, contact details & financial data for Alessa Therapeutics, Inc. of San Carlos, CA. Get the latest business insights from Dun & Bradstreet.See details»
Alessa Therapeutics - VentureRadar
Website: https://www.alessatherapeutics.com/ Alessa Therapeutics is focused on development, clinical validation and commercialization of local, sustained drug ...See details»
Alessa Therapeutics, Inc. Overview | SignalHire Company Profile
Alessa Therapeutics, Inc. headquarters is in San Carlos, California. Alessa Therapeutics, Inc. is in the sectors of: Biotech. To connect with Alessa Therapeutics, Inc.'s employee register on …See details»
Alessa Therapeutics - VentureRadar
"Alessa Therapeutics is a clinical-stage drug development company dedicated to creating selective and sustained localized drug delivery systems for early cancer interception.See details»
Alessa Therapeutics - PitchBook
Alessa Therapeutics General Information Description. Developer of a drug delivery implantable system designed to treat patients with prostate cancer. The company's system helps to administer anti-androgen drugs to the tumor in the …See details»
Alessa Therapeutics Announces Closing $15M Seed Financing
Dec 12, 2024 Alessa is financed by Mission BioCapital. For more information on Alessa Therapeutics, visit www.alessatherapeutics.com or email [email protected]. …See details»
Alessa Therapeutics - Craft
Alessa Therapeutics has 5 employees across 2 locations. See insights on Alessa Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Latest Press Releases & News - Alessa Therapeutics
Mar 26, 2024 Alessa Therapeutics announced the closing of a $15M seed financing led by Mission BioCapital joined by Johnson & Johnson (through its corporate venture capital …See details»
Founder Lodge | Alessa Therapeutics, Inc. raises $15,000,000 at …
Dec 13, 2024 I have founded AlessaTherapeutics focused on the sustained localized delivery of anti-cancer agents and i have many years of experience in bringing novel cancer therapeutics …See details»
Celanese Announces Collaboration with Alessa Therapeutics for …
Mar 1, 2023 Celanese Contacts Investor Relations Brandon Ayache +1 972 443 8509 [email protected] Media Relations – Global Brian Bianco +1 972 443 4400 …See details»
Alessa Therapeutics Announces First Patient Enrolled in Biolen-PC …
Oct 15, 2020 Alessa Therapeutics, Inc., a privately held drug development company developing an innovative and proprietary localized drug delivery technology for the treatment of prostate …See details»
Our Science - Alessa Therapeutics
Prostate Cancer Overview. Current treatment options for lower-risk cancer cases include either active surveillance (regular exams and repeat biopsies) or whole-gland treatment …See details»
New study results reinforce TAGRISSO® (osimertinib) as the …
1 day ago New study results presented at the European Lung Cancer Congress (ELCC) 2025, March 26 to 29, demonstrate the role of AstraZeneca’s TAGRISSO ® (osimertinib), as …See details»
Eterna Therapeutics Changes Name to Ernexa Therapeutics to
1 day ago Ernexa Therapeutics embarks on new strategic direction, shifting the company’s focus from delivering a cell therapy platform to prioritizing product developmentSee details»
New study results reinforce Tagrisso as the backbone therapy for …
1 day ago New study results presented at the European Lung Cancer Congress (ELCC) 2025, 26 to 29 March, demonstrate the role of AstraZeneca’s Tagrisso (osimertinib), as monotherapy …See details»